Ton Schumacher
InvestorVenture Partner at Third Rock Ventures
East Coast
Writes $100K – $5M checks · typically $1.5M
Find your path to Ton
113 people in our graph can introduce you to Ton.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Lisa Purcell to introduce you to Ton
You →Lisa · together at Third Rock Ventures →Ton
Ask Jamie Chen to introduce you to Ton
You →Jamie · 11 people · together at Third Rock Ventures →Ton
Sign up to find every way you can get introduced to Ton
- Your email: the people you already email who know Ton
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Ton
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Ton Schumacher is a Venture Partner at Third Rock Ventures, where he works on forming new companies in immunology and immuno-oncology. He is a senior member at The Netherlands Cancer Institute and a professor of Immunotechnology at Leiden University. Earlier, he founded AIMM Therapeutics and T cell factory (which was acquired by Kite Pharma) and served as CSO of Kite Pharma EU. His research on T cell recognition in human cancer has earned him honors including the Amsterdam Inventor Award, the Queen Wilhelmina Cancer Research Award, the Meyenburg Cancer Research Award, and the William B. Coley Award.
Beyond investing
- Founded
- Founded AIMM Therapeutics. Founded T cell factory, which was acquired by Kite Pharma.
- Education
- Completed his Ph.D. research with Hidde Ploegh, describing the rules of antigen presentation by MHC molecules. Carried out post-doctoral work with Peter Kim at The Whitehead Institute.
- Awards
- Received the Amsterdam Inventor Award for his work on T cell recognition in human cancer. Received the Queen Wilhelmina Cancer Research Award. Received the Meyenburg Cancer Research Award. Received the William B. Coley Award.
From Ton's own website — common ground for a warm intro.
Colleagues at Third Rock Ventures
Frequently asked questions
- Who is Ton Schumacher?
- Ton Schumacher is a Venture Partner at Third Rock Ventures, where he works on forming new companies in immunology and immuno-oncology. He is a senior member at The Netherlands Cancer Institute and a professor of Immunotechnology at Leiden University. Earlier, he founded AIMM Therapeutics and T cell factory (which was acquired by Kite Pharma) and served as CSO of Kite Pharma EU. His research on T cell recognition in human cancer has earned him honors including the Amsterdam Inventor Award, the Queen Wilhelmina Cancer Research Award, the Meyenburg Cancer Research Award, and the William B. Coley Award.
- Where does Ton Schumacher work?
- Ton Schumacher is Venture Partner at Third Rock Ventures.
- What check size does Ton Schumacher write?
- Ton Schumacher typically writes checks of $100K – $5M.
- What awards has Ton Schumacher received?
- Received the Amsterdam Inventor Award for his work on T cell recognition in human cancer. Received the Queen Wilhelmina Cancer Research Award. Received the Meyenburg Cancer Research Award. Received the William B. Coley Award.









